Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03797495 · ClinicalTrials.gov registry record
Study of Individuals Affected With Hypoplasminogenemia
A clinical trial of Plasminogen Deficiency, sponsored by Indiana Hemophilia &Thrombosis Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 20
- Study locations
NCT03797495 is a study of Plasminogen Deficiency that is actively recruiting participants, run by Indiana Hemophilia &Thrombosis Center. The registered enrollment target is 100 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT03797495, a study of Plasminogen Deficiency, is actively recruiting participants, sponsored by Indiana Hemophilia &Thrombosis Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is an Investigator initiated retrospective and prospective single cohort study. The study will utilize an international registry and develop a specimen biobank to provide an improved understanding of the natural history of hyposplasminogenemia, to elucidate the heterogeneity of phenotypic expression, identify markers to predict disease course, and inform improved therapeutic modalities
Conditions Studied
Study Locations (20)
Other
- Hospital Britanico Buenos Aires - Buenos Aires
- Children's Health Queensland Hospital and Health Service - South Brisbane
- Medical University of Innsbruck, University Clinic for Pediatrics and Adolescent Medicine - Innsbruck
- University of Saskatchewan - Saskatoon
New York
- Stony Brook University | Stony Brook Medicine - East Setauket
- SUNY Upstate Medical University, Pediatric Hematology/Oncology - Syracuse
Texas
- Cook Children's Medical Center - Forth Worth
- The University of Texas Health Science Center at Houston - Houston
Quebec
- CHU Sainte-Justine - Montreal
- CHU de Québec Université Laval - Québec
Alabama
- The University of Alabama (UAB) - Birmingham
Illinois
- Rush University Medical Center - Chicago
Indiana
- Indiana Hemophila @Thrombosis Center - Indianapolis
Minnesota
- University of Minnesota, Pediatric Hem/Onc & Cancer Survivorship Program - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2027-04-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03797495
The ClinicalTrials.gov registry entry for NCT03797495 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana Hemophilia &Thrombosis Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Plasminogen Deficiency appearing as the primary indexed condition, and to 0 interventions.
NCT03797495 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Other, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT03797495 about?
NCT03797495 is a clinical study titled "Study of Individuals Affected With Hypoplasminogenemia". This is an Investigator initiated retrospective and prospective single cohort study. The study will utilize an international registry and develop a specimen biobank to provide an improved understanding of the natural history of hyposplasminogenemia, to elucidate the heterogeneity of phenotypic expre...
What is the current status of trial NCT03797495?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2018-12-18. Estimated completion is 2027-04-19.
What conditions does trial NCT03797495 study?
This clinical trial studies the following conditions: Plasminogen Deficiency.
Who is sponsoring clinical trial NCT03797495?
This trial is sponsored by Indiana Hemophilia &Thrombosis Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03797495 being conducted?
This trial has 20 study locations across Alabama, Illinois, Indiana, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.